Triple threat: radiation, targeted drug, and immunotherapy take on brain metastases
Disease control
Recruiting now
This study is for people with breast cancer that has spread to the brain. It tests a treatment plan that starts with focused radiation plus a drug called olaparib, followed by an immunotherapy drug (durvalumab) and standard chemotherapy. The goal is to see if this combination is …
Phase: PHASE1, PHASE2 • Sponsor: Colette Shen • Aim: Disease control
Last updated May 15, 2026 11:53 UTC